TIM-3 TARGETING CAR-T CELLS, AS A POTENTIAL IMMUNOTHERAPY FOR AML

被引：0
|
作者：
Lee, S. [1 ]
Ye, Z. Y. [1 ]
Huang, H. [1 ]
Soh, M. K. [1 ]
Wang, Cheng-I [1 ]
机构：
[1] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore
来源：
HUMAN GENE THERAPY | 2018年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
ICLE8-0014
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 50 条
  • [31] Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
    Golubovskaya, Vita
    Wu, Lijun
    [J]. CANCERS, 2016, 8 (03):
  • [32] TIM-3 inhibitors: a promising strategy for tumor immunotherapy
    Lu, Lu
    Deng, Liufu
    [J]. TRENDS IN MOLECULAR MEDICINE, 2024, 30 (03) : 202 - 203
  • [33] Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy (vol 16, 101, 2023)
    Cai, Letong
    Li, Yuchen
    Tan, Jiaxiong
    Xu, Ling
    Li, Yangqiu
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [34] Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
    Kehry, Marilyn
    Horlick, Robert
    Bowers, Peter
    Jun, Toni
    Correia, Jean da Silva
    Graves, Jonathan
    Wang, Yan
    Laken, Haley
    King, David J.
    [J]. CANCER RESEARCH, 2015, 75
  • [35] TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
    Du, Wenwen
    Yang, Min
    Turner, Abbey
    Xu, Chunling
    Ferris, Robert L.
    Huang, Jianan
    Kane, Lawrence
    Lu, Binfeng
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)
  • [36] The regulation of TIM-3 transcription in T cells involves c-Jun binding but not CpG methylation at the TIM-3 promoter
    Yun, Su Jin
    Jun, Ka-Jung
    Komori, Kuniharu
    Lee, Mi Jin
    Kwon, Myung-Hee
    Chwae, Yong-Joon
    Kim, Kyongmin
    Shin, Ho-Joon
    Park, Sun
    [J]. MOLECULAR IMMUNOLOGY, 2016, 75 : 60 - 68
  • [37] The role of TIM-3 in sepsis: a promising target for immunotherapy?
    Wang, Changli
    Liu, Jinhai
    Wu, Qi
    Wang, Zhi
    Hu, Baoji
    Bo, Lulong
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
    Anderson, Ana C.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2014, 2 (05) : 393 - 398
  • [39] Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV
    Beck, Sarah E.
    Blankson, Joel N.
    [J]. MOLECULAR THERAPY, 2020, 28 (07) : 1561 - 1562
  • [40] Epigenetic and metabolic modification of CAR-T cells for optimal adoptive immunotherapy
    Kagoya, Yuki
    [J]. CANCER SCIENCE, 2021, 112 : 989 - 989
12345